35 results
Page 2 of 2
6-K
EX-99
zmfdycuvhj1ys5uak
8 Jan 14
Current report (foreign)
12:00am
424B3
l5bdrhzq3tvx58uy9s
8 Aug 13
Prospectus supplement
12:00am
424B3
8140f62vf4tqbfr24
15 Oct 12
Prospectus supplement
12:00am
F-1
10r0bge15 zgimhzt
2 Oct 12
Registration statement (foreign)
12:00am
424B3
nugvnw92g
28 Mar 12
Prospectus supplement
12:00am
20-F
nps96xw
22 Mar 12
Annual report (foreign)
12:00am
6-K
EX-99
kjq1oy7 60dt
28 Nov 11
BioLineRx Reports Third Quarter 2011 Financial Results
12:00am
6-K
EX-99
xn2y 4dq8j4sqgfx1tn
28 Nov 11
BioLineRx Reports Third Quarter 2011 Financial Results
12:00am
6-K
EX-1
kyc50rj8l ticumd
6 Sep 11
Orally-Available Molecule for the Treatment of
12:00am
6-K
EX-2
i0wz1qshfoeg2
23 Aug 11
Condensed Consolidated Interim Financial Statements
12:00am
20FR12B/A
1qd9k
15 Jul 11
Initial registration of securities (foreign private issuers) (amended)
12:00am
20FR12B
0mct8 fbs
1 Jul 11
Initial registration of securities (foreign private issuers)
12:00am
F-1
zuyccm03t 0k1l
24 Sep 10
Registration statement (foreign)
12:00am